Ronald C Renaud Jr Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

Ronald C Renaud Jr is President & CEO of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 160,452 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Ronald C Renaud Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 01 2024	SELL Sale (or disposition) back to the issuer	-	160,452 Reduced 100.0%	0 Common Stock
Dec 19 2023	BUY Exercise of conversion of derivative security	-	160,452 Added 50.0%	160,452 Common Stock

Also insider at

TBIO

Translate Bio, Inc. Healthcare

Chief Executive Officer

ATRA

Atara Biotherapeutics, Inc. Healthcare

IKNA

Ikena Oncology, Inc. Healthcare

Director

UPB

Upstream Bio, Inc.

RCR